ACELRX PHARMACEUTICALS INC
SEC Filing List
ACRX CIK: 0001427925
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | SHARTSIS FRIESE LLP /fa | 05/15/2026 | |||
| 8-K | Current report filing | Talphera, Inc. | RDG FILINGS /fa | 05/13/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Talphera, Inc. | RDG FILINGS /fa | 05/13/2026 | |
| SCHEDULE 13G/A | 05/12/2026 | ||||
| DEFA14A | Definitive additional proxy soliciting m... | Talphera, Inc. | RDG FILINGS /fa | 04/29/2026 | |
| DEF 14A | Definitive proxy statements | Talphera, Inc. | RDG FILINGS /fa | 04/29/2026 | |
| 4 | Statement of changes in beneficial owner... | Asadorian Raffi | Talphera, Inc. | 04/03/2026 | |
| 4 | Statement of changes in beneficial owner... | Angotti Vincent J. | Talphera, Inc. | 04/03/2026 | |
| 4 | Statement of changes in beneficial owner... | Aslam Shakil | Talphera, Inc. | 04/03/2026 | |
| 4 | Statement of changes in beneficial owner... | Dasu Badri N | Talphera, Inc. | 04/03/2026 | |
| No record found. | |||||
| Load More | |||||
